Par Pharmaceutical Announces Fourth-Quarter and Full-Year 2014 Conference Call
CHESTNUT RIDGE, N.Y., March 6, 2015 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Friday, March 13, 2015 at 2:00 p.m. EDT to review its results of operations for the fourth quarter and full year ended December 31, 2014. Par is privately held and currently makes certain financial information available to the public in its filings with the Securities and Exchange Commission and will make certain other information available on its website by following the instructions at http://www.parpharm.com/financialinfo. Par will file its financial statements for the year ended December 31, 2014 with the SEC prior to the call.
Only holders of Par's debt securities, prospective holders of Par's debt securities and research analysts who cover or intend to cover Par and its debt securities may participate in the conference call by requesting access to the secured area of Par's website at http://www.parpharm.com/financialinfo for dial-in information.
About Par Pharmaceutical Companies
Par Pharmaceutical Companies, Inc. is a privately-held, U.S.-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit www.parpharm.com.
SOURCE Par Pharmaceutical Companies
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article